Open access · OA
via Europe PMC
Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration.
Savino A, Liaci C, Bertani I, Rando S, Camera M, Merlo GR, Avalle L, Poli V, Kalebic N, Iorio F.
Aging cell · 2026
Abstract
Psychedelic compounds such as lysergic acid diethylamide (LSD) are increasingly studied for their neuroplastic effects and potential relevance to brain ageing and neurodegenerative conditions, including dementia. These processes are characterised by transcriptional changes involving progressive synaptic dysfunction and altered neuron-glia interactions. In computational drug discovery, the transcriptional signature reversion principle proposes that compounds inducing gene expression states opposite to disease-associated programmes may have therapeutic potential by counteracting disease-associated phenotypes. We therefore asked whether LSD-induced transcriptional changes oppose gene expression programmes associated with brain ageing and dementia, thereby providing a data-driven rationale for its potential relevance to age-associated cognitive decline and a starting point for investigating the underlying molecular mechanisms. Combining cross-species transcriptomic analyses with experimental validation, we show that transcriptional profiles induced by chronic LSD treatment in rats are strongly anti-correlated with ageing-associated gene expression changes in the human prefrontal cortex and, to a lesser extent, with dementia-associated programmes. This relationship is reproducible across datasets and species and is significantly stronger compared to a broad panel of pharmacological perturbations. Independent acute LSD treatment in mice recapitulated the opposition to ageing-associated transcriptional signatures across multiple doses. Moreover, short-term LSD treatment attenuated amyloid-β-induced structural, molecular and transcriptional alterations in primary cortical cultures. Together, these findings provide a transcriptionally grounded rationale for investigating LSD and related compounds in brain ageing and neurodegeneration, while identifying molecular and cellular programmes that can guide future mechanistic and therapeutic studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/acel.70793
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
A, S., C, L., I, B., S, R., M, C., GR, M., L, A., V, P., N, K., & F., I. (2026). Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration. <em>Aging cell</em>. https://doi.org/10.1111/acel.70793
Vancouver
A S, C L, I B, S R, M C, GR M, et al. Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration. Aging cell. 2026. doi:10.1111/acel.70793.
BibTeX
@article{savino2026Lyserg,
title = {Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration.},
author = {Savino A and Liaci C and Bertani I and Rando S and Camera M and Merlo GR and Avalle L and Poli V and Kalebic N and Iorio F.},
journal = {Aging cell},
year = {2026},
doi = {10.1111/acel.70793},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2026
Preprint
Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programs
bioRxiv (Cold Spring Harbor Laboratory) 2026
Preprint · CC-BY
CDKL5 deficiency alters cell subtype-specific molecular programmes and intercellular signalling in the mouse hippocampus
Biogerontology 2025
Citation only
Hyperoside extends lifespan in Caenorhabditis elegans through SEK-1/PMK-1/SKN-1 pathway.
Biomolecules 2025
Open access · CC-BY
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
The Journal of Clinical Endocrinology & Metabolism 2015
Open access · OA
Acute Sleep Loss Induces Tissue-Specific Epigenetic and Transcriptional Alterations to Circadian Clock Genes in Men
European journal of pharmacology 2026
Citation only